Portfolio company
Lumora
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops molecular diagnostic products for clinical and industrial markets, providing sample preparation and detection technology for food safety and medical diagnostics customers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Figura Analytics
This company develops nanopore technology for rapid liquid analysis and contaminant detection for customers in the food, beverage, and healthcare sectors.
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Abacus Diagnostica
This company develops molecular diagnostic systems for infectious disease testing, serving hospital laboratories and healthcare units.
FluoretiQ Limited
This company develops rapid point-of-care diagnostic tests that identify bacterial infections and antibiotic sensitivity for clinicians and veterinarians.
Enumera Molecular
The company develops genomic analysis platforms and workflows for clinical laboratories to perform rapid and cost-effective liquid biopsy and diagnostic testing.
NeuMoDx Molecular
The company develops automated molecular diagnostic systems and reagents for nucleic acid testing in clinical and hospital laboratories.
Llusern Scientific
This company develops portable molecular diagnostic platforms and urinary tract infection testing kits for professional healthcare and veterinary providers.
